XML 106 R81.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCK COMPENSATION PLANS (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-based Compensation Arrangements by Share-based Payment Award      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 6 years 6 years 6 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value $ 73.08 $ 72.27 $ 68.35
Number of shares purchased by eligible employees 0.3 0.3 0.2
Fair value of the employee's purchase right $ 47.56 $ 49.19 $ 62.50
Risk free interest rate 4.10% 3.40% 2.00%
Expected volatility 30.00% 29.80% 28.60%
Expected dividend yield 1.30% 1.40% 0.90%
Shares of common stock authorized for issuance under the employee stock purchase plan 1.8    
The employee stock purchase plan permits employees to purchase shares of common stock at a certain percentage of the market price (in hundredths) 85.00%    
Expense related to the Company's employee stock purchase plan $ 14.9 $ 13.8 $ 14.8
Unrecognized compensation cost related to nonvested restricted stock and performance share-based compensation arrangements $ 100.6    
Performance share awards, vesting conditions Performance share awards are subject to certain earnings per share, revenue, and total shareholder return targets    
Restricted stock, vesting increment one-third increments beginning on the first anniversary of the grant    
Cash received by the Company $ 6.5 2.9 7.1
Share-based Payment Arrangement, Exercise of Option, Tax Benefit 1.6 0.7 1.8
Aggregate intrinsic value $ 1.6 0.7 8.2
Unrecognized compensation cost weighted average expected future recognition period (in years) 1 year 8 months 12 days    
Restricted stock and performance share compensation expense $ 96.6 111.1 97.7
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 9.0    
Shares available for grant under the Company's stock option plans 2.8    
Stock option plan expense $ 5.2 $ 3.8 $ 4.3
Employee Stock Purchase Plan [Member]      
Share-based Compensation Arrangements by Share-based Payment Award      
Risk free interest rate 5.00% 5.00% 1.30%
Expected volatility 27.90% 30.00% 30.00%
Expected dividend yield 1.30% 1.40% 0.90%
Restricted Stock and Performance Shares [Member]      
Share-based Compensation Arrangements by Share-based Payment Award      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value $ 222.52    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 0.9 1.0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 226.44 $ 248.41  
Number of options granted 0.5    
Weighted-average grant date fair value, granted $ 224.23    
Number of options vested (0.5)    
Weighted-average grant date fair value, vested $ 264.80    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (0.1)    
Stock Options [Member]      
Share-based Compensation Arrangements by Share-based Payment Award      
Aggregate intrinsic value, exercisable options $ 31.2    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 0.6 0.6  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 180.29 $ 174.45  
Number of options granted 0.1    
Weighted-average exercise price per option granted $ 223.94    
Weighted-average remaining contractual term of options outstanding (in years) 5 years 7 months 6 days    
Aggregate intrinsic value of options outstanding $ 32.1    
Number of options exercisable 0.5    
Weighted-average exercise price per exercisable option $ 165.99    
Weighted-average remaining contractual term, exercisable options (in years) 4 years 8 months 12 days